We examined memory CD8+CD44hi T cells and CD3−NK1.1+ cells28, and the percentages of these cells from the tumour and spleen post vvDD-IL-2-RG treatment were increased compared to those treated with other viruses (Fig. 3g and Supplementary Fig. 11b–d). This evidence concerns the gene CD8A and neoplasm.